CD26 (Protein|Antibody|cDNA Clone|ELISA Kit)

All CD26 reagents are produced in house and quality controlled, including 14 CD26 Antibody, 41 CD26 Gene, 8 CD26 Lysate, 8 CD26 Protein, 2 CD26 qPCR. All CD26 reagents are ready to use.

Recombinant CD26 proteins are expressed by HEK293 Cells with fusion tags as N-human IgG1-Fc, C-His, N-cleavage.

CD26antibodies are validated with different applications, which are FCM, ELISA, IHC-P.

CD26cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each CD26 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

CD26 Protein (8)

Species

CD26 Protein, Human, Recombinant (His Tag)

10688-H08H

Expression host: HEK293 Cells

Human DPP4 / CD26 Protein 9021

CD26 Protein, Human, Recombinant

10688-HNCH

Expression host: HEK293 Cells

Human DPP4 / CD26 Protein 9022

CD26 Protein, Mouse, Recombinant (His Tag)

50718-M08H

Expression host: HEK293 Cells

Mouse DPP4 / CD26 Protein 11863

CD26 Protein, Cynomolgus, Recombinant

90180-CNCH

Expression host: HEK293 Cells

Cynomolgus DPP4 / CD26 Protein 12861

CD26 Protein, Cynomolgus, Recombinant (Fc Tag)

90180-C01H

Expression host: HEK293 Cells

Cynomolgus DPP4 / CD26 Protein 12859

CD26 Protein, Human, Recombinant (Fc Tag)

10688-H01H

Expression host: HEK293 Cells

Human DPP4 / CD26 Protein 9020

CD26 Protein, Mouse, Recombinant (Fc Tag)

50718-M01H

Expression host: HEK293 Cells

Mouse DPP4 / CD26 Protein 11862

CD26 Protein, Cynomolgus, Recombinant (ECD, His Tag)

90180-C08H

Expression host: HEK293 Cells

Cynomolgus DPP4 / CD26 Protein 12860
Go

CD26 Antibody (14)

Application Clonality
Host

Anti-CD26 Antibody (APC)

50718-R007-A

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17625

Anti-CD26 Antibody (PE)

50718-R009-P

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17619

Anti-CD26 Antibody

102004-T08

Application: IHC-P

Clonality: PAb

Human CD26 Immunohistochemistry(IHC) 19066

Anti-CD26 Antibody (FITC)

50718-R009-F

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17614

Anti-CD26 Antibody (PE)

10688-MM05-P

Application: FCM

Clonality: MAb

Human DPP4 / CD26 Flow Cytometry (FC) 5281

Anti-CD26 Antibody (APC)

50718-R009-A

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17626

Anti-CD26 Antibody

50718-T16

Application: ELISA

Clonality: PAb

Anti-CD26 Antibody (PE)

50718-R007-P

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17618

Anti-CD26 Antibody

50718-R007

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17513

Anti-CD26 Antibody

50718-R009

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17511

Anti-CD26 Antibody

10688-MM05

Application: FCM

Clonality: MAb

Human DPP4 / CD26 Flow Cytometry (FC) 5283

Anti-CD26 Antibody (FITC)

10688-MM05-F

Application: FCM

Clonality: MAb

Human DPP4 / CD26 Flow Cytometry (FC) 5281

Anti-CD26 Antibody (APC)

10688-MM05-A

Application: FCM

Clonality: MAb

Human DPP4 / CD26 Flow Cytometry (FC) 5282

Anti-CD26 Antibody (FITC)

50718-R007-F

Application: FCM

Clonality: MAb

Mouse DPP4 / CD26 Flow Cytometry (FC) 17629
Go

CD26 cDNA Clone (41)

Human
Rhesus
Mouse
Rat

CD26 qPCR Primer (2)

CD26 Lysate (8)

Dipeptidyl peptidase-4 (DPP4) or adenosine deaminase complexing protein 2 (ADCP 2) or T-cell activation antigen CD26 is a serine exopeptidase belonging to the S9B protein family that cleaves X-proline dipeptides from the N-terminus of polypeptides, such as chemokines, neuropeptides, and peptide hormones. The enzyme is a type II transmembrane glycoprotein, expressed on the surface of many cell types. It is also present in serum and other body fluids in a truncated form (sCD26/DPPIV). The soluble CD26 (sCD26) as a tumour marker for the detection of colorectal cancer (CRC) and advanced adenomas. As both a regulatory enzyme and a signalling factor, DPP4 has been evaluated and described in many studies. DPP4 inhibition results in increased blood concentration of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). This causes an increase in glucose-dependent stimulation, resulting in a lowering of blood glucose levels. Recent studies have shown that DPP4 inhibitors can induce a significant reduction in glycosylated haemoglobin (HbA(1c)) levels, either as monotherapy or as a combination with other antidiabetic agents. Research has also demonstrated that DPP4 inhibitors portray a very low risk of hypoglycaemia development, and are a new pharmacological class of drugs for treating Type 2 diabetes.

Protein
Antibody
Gene
qPCR
Lysate
Close